Literature DB >> 11099231

TMC-89A and B, new proteasome inhibitors from streptomyces sp. TC 1087.

Y Koguchi1, M Nishio, S Suzuki, K Takahashi, T Ohnuki, S Komatsubara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11099231     DOI： 10.7164/antibiotics.53.967

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  5 in total

Review 1.  The ubiquitin-proteasome pathway and proteasome inhibitors.

Authors:  J Myung; K B Kim; C M Crews
Journal:  Med Res Rev       Date:  2001-07       Impact factor: 12.944

2.  Development and characterization of proteasome inhibitors.

Authors:  Kyung Bo Kim; Fabiana N Fonseca; Craig M Crews
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

Review 3.  Proteasome regulators: activators and inhibitors.

Authors:  Li Huang; Chin Ho Chen
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

4.  Genetic basis for the biosynthesis of the pharmaceutically important class of epoxyketone proteasome inhibitors.

Authors:  Michelle Schorn; Judith Zettler; Joseph P Noel; Pieter C Dorrestein; Bradley S Moore; Leonard Kaysser
Journal:  ACS Chem Biol       Date:  2013-11-08       Impact factor: 5.100

5.  Natural product scaffolds as inspiration for the design and synthesis of 20S human proteasome inhibitors.

Authors:  Grace E Hubbell; Jetze J Tepe
Journal:  RSC Chem Biol       Date:  2020-09-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.